-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
H3K4 methylation modification plays a key role in enhancer activity regulation, transcriptional activation, and cell fate decisions, and its abnormalities can lead to the occurrence of a variety of leukemias and malignant tumors
Recently, the Chen Yong Research Group of the Center for Excellence in Molecular and Cell Science (Institute of Biochemistry and Cell Biology) of the Chinese Academy of Sciences published in the journal iScience entitled: DPY30 acts as an ASH2L-specific stabilizer to stimulate the enzyme activity of MLL family methyltransferases on different Substrates' research paper reveals the molecular mechanism
In this study, the team found that DPY30 can enhance the activity
The research team then elucidated the methyltransferase activity
Molecular mechanism of DPY30 promoting methyltransferase activity of MLL complexes
DPY30 is highly expressed in a variety of cancers, and previous studies have shown that the pro-cancer effects of DPY30 are associated
Zhao Lijie, a doctoral student at the Center for Molecular Cell Excellence of the Chinese Academy of Sciences, is the first author of the paper, and researcher Chen Yong is the corresponding author
Original source:
Lijie Zhao, et al.